(1S,2R,3S,4R,5S)-4-(6-(((1R,2S,4S)-bicyclo[2.2.1]heptan-2-yl)amino)-2-chloro-9H-purin-9-yl)-2,3-dihydroxy-N-(2-hydroxyethyl)bicyclo[3.1.0]hexane-1-carboxamide

ID: ALA4579650

Chembl Id: CHEMBL4579650

PubChem CID: 155565326

Max Phase: Preclinical

Molecular Formula: C21H27ClN6O4

Molecular Weight: 462.94

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(NCCO)[C@@]12C[C@@H]1[C@@H](n1cnc3c(N[C@H]4C[C@H]5CC[C@@H]4C5)nc(Cl)nc31)[C@H](O)[C@@H]2O

Standard InChI:  InChI=1S/C21H27ClN6O4/c22-20-26-17(25-12-6-9-1-2-10(12)5-9)13-18(27-20)28(8-24-13)14-11-7-21(11,16(31)15(14)30)19(32)23-3-4-29/h8-12,14-16,29-31H,1-7H2,(H,23,32)(H,25,26,27)/t9-,10+,11+,12-,14+,15-,16-,21-/m0/s1

Standard InChI Key:  AWXOZEOHMQXOAJ-NQNJJODYSA-N

Alternative Forms

  1. Parent:

    ALA4579650

    ---

Associated Targets(Human)

ADORA1 Tclin Adenosine A1 receptor (17603 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA2A Tclin Adenosine A2a receptor (16305 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA3 Tchem Adenosine A3 receptor (15931 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR2B Tclin Serotonin 2b (5-HT2b) receptor (10323 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRK1 Tclin Kappa opioid receptor (16155 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Adora1 Adenosine A1 receptor (162 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Adora2a Adenosine A2a receptor (87 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Adora3 Adenosine A3 receptor (257 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 462.94Molecular Weight (Monoisotopic): 462.1782AlogP: 0.47#Rotatable Bonds: 6
Polar Surface Area: 145.42Molecular Species: NEUTRALHBA: 9HBD: 5
#RO5 Violations: HBA (Lipinski): 10HBD (Lipinski): 5#RO5 Violations (Lipinski):
CX Acidic pKa: 13.12CX Basic pKa: 2.15CX LogP: -0.23CX LogD: -0.23
Aromatic Rings: 2Heavy Atoms: 32QED Weighted: 0.39Np Likeness Score: 0.13

References

1. Tosh DK, Rao H, Bitant A, Salmaso V, Mannes P, Lieberman DI, Vaughan KL, Mattison JA, Rothwell AC, Auchampach JA, Ciancetta A, Liu N, Cui Z, Gao ZG, Reitman ML, Gavrilova O, Jacobson KA..  (2019)  Design and in Vivo Characterization of A1 Adenosine Receptor Agonists in the Native Ribose and Conformationally Constrained (N)-Methanocarba Series.,  62  (3): [PMID:30605331] [10.1021/acs.jmedchem.8b01662]

Source